| Name | Title | Contact Details |
|---|
OXiGENE is a biopharmaceutical company developing new and improved therapeutics that have the potential to deliver significant medical benefits to patients with cancer and serious medical conditions. Our primary focus is developing first-in-class anti-vascular drugs referred to as vascular disrupting agents (VDAs). Our lead compound in clinical development is fosbretabulin. VDAs are a new and highly differentiated class of anti-vascular drug that target existing tumor vasculature, leading to extensive tumor cell death. VDAs target the tumor vasculature rather than the tumor cells and therefore have broad potential therapeutic utility in cancer. Because VDAs act differently than anti-angiogenic drugs or cytotoxic chemotherapy drugs, VDAs are potentially complementary with anti-angiogenic drugs and chemotherapeutic agents. OXiGENE has ongoing VDA drug development programs and is committed to advancing the science of VDAs and their potential as innovative therapies to address unmet medical needs.
Carestream`s products make a difference every day. Carestream Health is a health imaging and information technology solutions company. We provide medical and healthcare IT solutions and X-ray film and digital X-ray products for the non-destructive testing market worldwide. We also provide product, technical, and service support, including remote equipment and software management services. In addition, we own over 600 patents in digital imaging, healthcare IT, film, and imaging chemistry. We became Carestream in 2007 when Onex Corporation purchased Eastman Kodak`s Health Group. Today, we employ approximately 6,000 people who serve a global customer base in over 150 countries. Carestream is headquartered in Rochester, New York, with locations around the world.
Minntech Corporation is engaged in the development, manufacture and marketing of medical supplies and devices, sterilants and filtration and separation products. The Company's products are used primarily in kidney dialysis and in open-heart surgery. The
ResMed (NYSE: RMD, ASX: RMD), a world-leading connected health company with more than 4 million cloud-connected devices for daily remote patient monitoring, changes lives with every breath. Its award-winning devices and software solutions help treat and manage sleep apnea, chronic obstructive pulmonary disease and other respiratory conditions. Its 6,000-member team strives to improve patients’ quality of life, reduce the impact of chronic disease and save healthcare costs in more than 120 countries.
Meditrina, a small startup company located in San Jose, CA, and founded in 2016 developed the Aveta™ hysteroscopy suite which was designed to provide physicians with the best care in their diagnosis and treatment of endometrial polyps and uterine fibroids.